A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

Clinical trial NCT05954988 · COMPLETED

Trial details

NCT number: NCT05954988
Sponsor: Rein Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-07-06
Primary completion: 2024-09-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.